TRIP
66
2
SLG
38
3
CHD
37
5
HPE
38
2
RIG
35
6
MSI
57
3
VNO
49
2
DAL
64
3
CAH
47
2
PCG
66
5
MMM
37
2
FDX
36
3
AMT
33
3
MDLZ
36
6
DHR
40
5
KMI
73
4
FITB
35
2
HIG
51
4
CMG
64
3
MTB
40
2
TRIP
66
2
SLG
38
3
CHD
37
5
HPE
38
2
RIG
35
6
MSI
57
3
VNO
49
2
DAL
64
3
CAH
47
2
PCG
66
5
MMM
37
2
FDX
36
3
AMT
33
3
MDLZ
36
6
DHR
40
5
KMI
73
4
FITB
35
2
HIG
51
4
CMG
64
3
MTB
40
2
Financhill
Back

Eton Pharmaceuticals 10K Form

Buy
71

ETON
Eton Pharmaceuticals

Last Price:
$13.52
Seasonality Move:
-5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ETON News And Ratings

See the #1 stock for the next 7 days that we like better than ETON

ETON Financial Statistics

Sales & Book Value

Annual Sales: $31.6M
Cash Flow: $3M
Price / Cash Flow: 1375.01
Annual Sales: $0.62
Price / Book: 20.47

Profitability

EPS (TTM): -0.22000
Net Income (TTM): $-5.5M
Gross Margin: $21.1M
Return on Equity: -35.45%
Return on Assets: -16.95%

Eton Pharmaceuticals Earnings Forecast

Key Eton Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for ETON is 66.56%.
  • The Selling, General & Administrative Expenses for ETON have been equal to 59.83% of Gross Profit Margin.
  • The Research & Development expenses have been 10.50% of Revenue.
  • The Net Earning history of ETON is -2.96% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Eton Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ETON
CUSIP: 29772L
Website: etonpharma.com

Debt

Debt-to-Equity Ratio: 0.26
Current Ratio: 1.51
Quick Ratio: 1.31

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 30.14

ETON Technical Analysis vs Fundamental Analysis

Buy
71
Eton Pharmaceuticals (ETON) is a Buy

Is Eton Pharmaceuticals a Buy or a Sell?